Craanen M E, Offerhaus G J, Tytgat G N
Department of Gastroenterology, University of Amsterdam, The Netherlands.
Gastrointest Endosc Clin N Am. 1997 Jan;7(1):147-64.
Molecular biology has become an integral part of research aimed at improving diagnosis, therapy, and ultimately prevention of malignant disease. This article focuses on the current possibilities and limitations of molecular biology to improve existing screening and surveillance protocols in specific gastrointestinal disease entities frequently encountered in routine clinical practice.
分子生物学已成为旨在改善恶性疾病诊断、治疗并最终实现预防的研究中不可或缺的一部分。本文重点关注分子生物学在改善常规临床实践中常见的特定胃肠道疾病实体现有筛查和监测方案方面的当前可能性和局限性。
